We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Settles OxyContin Patent; Inks Intuniv Deal With Shire
Actavis Settles OxyContin Patent; Inks Intuniv Deal With Shire
May 3, 2013
In a recently reached settlement agreement, Purdue Pharma granted Actavis a license to sell a generic version of its abuse-deterrent OxyContin as early as Jan. 1, 2014.